UB Paderborn / Katalog / Suche / in CDI

Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer

Current treatment options in oncology, 2006-10, Vol.7 (5), p.381-388

2006

Volltextzugriff (PDF)

Synovial sarcoma with intra-abdominal metastasis causing hemoperitoneum: a case-report

World journal of surgical oncology, 2023-01, Vol.21 (1), p.24-24, Article 24

2023

Volltextzugriff (PDF)

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next‐Generation Sequencing Panel

The oncologist (Dayton, Ohio), 2014-06, Vol.19 (6), p.616-622

2014

Volltextzugriff (PDF)

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

Clinical therapeutics, 2016-04, Vol.38 (4), p.778-793

2016

Volltextzugriff (PDF)

Inhibition of angiogenesis in the treatment of non‐small cell lung cancer

Cancer science, 2007-12, Vol.98 (12), p.1825-1830

2007

Volltextzugriff (PDF)

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma

Cancers, 2023-05, Vol.15 (9), p.2617

2023

Volltextzugriff (PDF)

Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas

Current Treatment Options in Oncology, 2016-02, Vol.17 (2), p.11-11, Article 11

2016

Volltextzugriff (PDF)

Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms

American journal of roentgenology (1976), 2013-03, Vol.200 (3), p.475

2013

Volltextzugriff (PDF)

Signal transduction pathway analysis in desmoid‐type fibromatosis: Transforming growth factor–β, COX2 and sex steroid receptors

Cancer science, 2012-12, Vol.103 (12), p.2173-2180

2012

Volltextzugriff (PDF)

Inadvertent Inguinal Sarcoma Excision during Hernia Surgery: Outcomes, Gender Analysis, and Prevention

International journal of surgical oncology, 2020-12, Vol.2020, p.8374790-9

2020

Volltextzugriff (PDF)

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

Journal of clinical oncology, 2016-11, Vol.34 (32), p.3898-3905

2016

Volltextzugriff (PDF)

Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1604-1612

2021

Volltextzugriff (PDF)

Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience

Future oncology (London, England), 2022-04, Vol.18 (13), p.1595-1607

2022

Volltextzugriff (PDF)

Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer

Journal of clinical oncology, 2021-04, Vol.39 (10), p.1165-1184

2021

Volltextzugriff (PDF)

Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma

The Journal of pathology, 2010-04, Vol.220 (5), p.608-617

2010

Volltextzugriff (PDF)

Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity?

Human pathology, 2013-04, Vol.44 (4), p.656-663

2013

Volltextzugriff (PDF)

Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

Journal of clinical oncology, 2022-04, Vol.40 (12), p.1291-1300

2022

Volltextzugriff (PDF)

Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma

Modern pathology, 2009-11, Vol.22 (11), p.1432-1438

2009

Volltextzugriff (PDF)

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International journal of cancer, 2022-03, Vol.150 (6), p.993-1006

2022

Volltextzugriff (PDF)

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study

Investigational new drugs, 2020-06, Vol.38 (3), p.812-820

2020

Volltextzugriff (PDF)

Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy

Human pathology, 2012-09, Vol.43 (9), p.1418-1424

2012

Volltextzugriff (PDF)

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

Cancer, 2023-12, Vol.129 (23), p.3772-3782

2023

Volltextzugriff (PDF)

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Clinical cancer research, 2022-01, Vol.28 (2), p.298-307

2022

Volltextzugriff (PDF)

Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2020, Vol.85 (1), p.173-183

2020

Volltextzugriff (PDF)

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

The Lancet (British edition), 2024-04, Vol.403 (10435), p.1460-1471

2024

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer

Synovial sarcoma with intra-abdominal metastasis causing hemoperitoneum: a case-report

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next‐Generation Sequencing Panel

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

Inhibition of angiogenesis in the treatment of non‐small cell lung cancer

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma

Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas

Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms

Signal transduction pathway analysis in desmoid‐type fibromatosis: Transforming growth factor–β, COX2 and sex steroid receptors

Inadvertent Inguinal Sarcoma Excision during Hernia Surgery: Outcomes, Gender Analysis, and Prevention

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma

Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors

Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience

Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer

Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma

Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity?

Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study

Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Suchergebnisse filtern